Female ovarian steroids in epilepsy: A cause or remedy

Pharmacological Reports

Volumn 65, Issue 4, 2013, Pages 802-812

  Alam, Mohammad N ^a   Ahmad, Aakifa ^b   Al Abbasi, Fahad A ^c   Ahmad, Aftab ^c  

^a KING KHALID UNIVERSITY   (Saudi Arabia)

^b Monad University   (India)

^c KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Central nervous system; Clinical; Epilepsy; Estrogens; Preclinical; Progesterone; Seizures

Indexed keywords

ANTICONVULSIVE AGENT; ESTRADIOL; ESTRIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTRONE; PROGESTERONE; PROGESTERONE RECEPTOR;

ANTICONVULSANT ACTIVITY; BLOOD BRAIN BARRIER; BRAIN FUNCTION; CENTRAL NERVOUS SYSTEM; DISEASE MODEL; DRUG MECHANISM; ENDOCRINE SYSTEM; EPILEPSY; FEMALE; GENITAL SYSTEM; HORMONE ACTION; HUMAN; LATENT PERIOD; MOLECULAR WEIGHT; NERVE CELL EXCITABILITY; NEUROPROTECTION; NONHUMAN; PATHOGENESIS; PREVALENCE; REVIEW; SEIZURE; TREATMENT DURATION;

ANIMALS; ANTICONVULSANTS; BRAIN; EPILEPSY; ESTROGENS; FEMALE; HUMANS; MODELS, NEUROLOGICAL; OVARY; PROGESTERONE;

EID: 84886514361     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(13)71061-2     Document Type: Review

References (117)

1. Akwa Y, Sananes N, Gouezou M, Robel P, Baulieu EE, Le Goascogne C: Astrocytes and neurosteroids: metabolism of pregnenolone and dehydroepiandrosterone. Regulation by cell density. J Cell Biol, 1993, 121, 135-143.
2. Ali A, Pillai KK, Vohora D: Evidence of the antiepileptic potential of amiloride with neuropharmacological benefits in rodent models of epilepsy and behaviour. Epilepsy Behav, 2004, 145, 880-884.
3. Allport VC, Pieber D, Slater DM, Newton R, White JO, Bennett PR: Human labour is associated with nuclear factor-kB activity which mediates cyclo-oxygenase-2 expression and is involved with the functional progesterone withdrawal. Mol Hum Reprod, 2001, 7, 581-586.
4. Allport VC, Slater DM, Newton R, Bennett PR: NF-kB and AP-1 are required for cyclo-oxygenase 2 gene expression in amnion epithelial cell line (WISH). Mol Hum Reprod, 2000, 6, 561-565.
5. Attali G, Weizman A, Gil-Ad I: Opposite modulatory effects of ovarian hormones on rat brain dopamine and serotonin transporters. Brain Res, 1997, 756, 153-159.
6. Backstrom T: Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta Neurol Scand, 1976, 54, 321-347.
7. Backstrom T, Zetterlund B, Blom S, Romano M: Effect of intravenous progesterone infusions on the epileptic discharge frequency in women with partial epilepsy. Acta Neurol Scand, 1984, 69, 240-248.
8. Barha CK, Galea LA: Influence of different estrogens on neuroplasticity and cognition in the hippocampus. Biochim Biophys Acta, 2010, 180, 1056-1067.
9. Banerji PN, Filippi D, Allen Hauser W: The descriptive epidemiology of epilepsy - a review. Epilepsy Res, 2009, 85, 31-45.
10. Becker JB, Rudick CN: Rapid effects of estrogen or progesterone on the amphetamine induced increase in striatal dopamine are enhanced by estrogen priming: a microdialysis study. Pharmacol Biochem Behav, 1999, 64, 53-57.
11. Bitran D, Foley M, Audette D, Leslie N, Frye CA: Activation of peripheral mitochondrial benzodiazepine receptors in the hippocampus stimulates allopregnanolone synthesis and produces anxiolytic-like effects in the rat. Psychopharmacology (Berl), 2000, 151, 64-71.
12. Bonuccelli U, Melis GB, Paoletti AM, Fioretti P, Murri L, Muratorio A: Unbalanced progesterone and estradiol secretion in catamenial epilepsy. Epilepsy Res, 1989, 3, 100-106.
13. Budziszewska B, Leoekiewicz M, Kubera M, Jaworska- Feil L, Kajta M, Lasoñ W: Estrone, but not 17b-estradiol, attenuates kainate-induced seizures and toxicity in male mice. Exp Clin Endocrinol Diabetes, 2001, 109, 168-173.
14. Buterbaugh GG: Estradiol replacement facilitates the acquisition of seizures kindled from the anterior neocortex in female rats. Epilepsy Res, 1989, 4, 207-215.
15. Buterbaugh GG, Hudson GM: Estradiol replacement to female rats facilitates dorsal hippocampal but not ventral hippocampal kindled seizure acquisition. Exp Neurol, 1991, 111, 55-64.
16. Craig CR: Anticonvulsant activity of steroids separability of anticonvulsant from hormonal effects. J Pharmacol Exp Ther, 1966, 153, 337-343.
17. Dawson RJ, Wallace DR: Kainic acid-induced seizures in aged rats: Neurochemical correlates. Brain Res Bull, 1992, 29, 459-468.
18. Djebaili M, Guo QM, Pettus EH, Hoffman SW, Stein DG: The neurosteroids progesterone and allopregnanolone reduce cell death, gliosis, and functional deficits after traumatic brain injury in rats. J Neurotrauma, 2005, 22, 106-118.
19. Djebaili M, Hoffman SW, Stein DG: Allopregnanolone and progesterone decrease cell death and cognitive deficits after a contusion of the rat pre-frontal cortex. Neuroscience, 2004, 123, 349-359.
20. Dluzen DE, Ramirez VD: Progesterone enhances L-dopa-stimulated dopamine release from the caudate nucleus of freely behaving ovariectomized- estrogenprimed rats. Brain Res, 1989, 494, 122-128.
21. Edwards HE, Burnham WM, Mendonca A, Bowlby DA, MacLusky NJ: Steroid hormones affect limbic after discharge thresholds and kindling rates in adult female rats. Brain Res, 1999, 838, 136-150.
22. Fang H, Tong W, Shi LM, Blair R, Perkins R, Branham W, Hass BS et al.: Structure-Activity relationships for a large diverse set of natural, synthetic, and environmental estrogens. Chem Res Toxicol, 2001, 14, 280-294.
23. Fernández-Ruiz JJ, de Miguel R, Hernández ML, Ramos JA: Time-course of the effects of ovarian steroids on the activity of limbic and striatal dopaminergic neurons in female rat brain. Pharmacol Biochem Behav, 1990, 36, 603-606.
24. Frye CA, Rhodes ME, Walf A, Harney J: Progesterone reduces pentylenetetrazol-induced ictal activity of wildtype mice but not those deficient in type I 5a reductase. Epilepsia, 2002, 43, 14-17.
25. Frye CA, Scalise TJ: Anti-seizure effects of progesterone and 3a,5a-THP in kainic acid and perforant pathway models of epilepsy. Psychoneuroendocrinology, 2000, 25, 407-420.
26. Galanopoulou AS, Alm EM, Velísková J: Estradiol reduces seizure-induced hippocampal injury in ovariectomized female but not in male rats. Neurosci Lett, 2003, 342, 201-205.
27. Garcia-Segura LM, Azcoitia I, DonCarlos LL: Neuroprotection by estradiol. Prog Neurobiol, 2001, 63, 29-60.
28. Gevorkyan ES, Nazaryan KB, Kostanyan AA: Modifying effect of estradiol and progesterone on epileptic activity of the rat brain. Neurosci Behav Physiol, 1989, 19, 412-415.
29. Gomez-Mancilla B, Bedard PJ: Effect of estrogen and progesterone on L-dopa induced dyskinesia in MPTPtreated monkeys. Neurosci Lett, 1992, 135, 129-132.
30. Goodman Y, Bruce AJ, Cheng BB,MattsonMP: Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid b-peptide toxicity in hippocampal neurones. J Neurochem, 1996, 66, 1836-1844.
31. Gowers WR: Epilepsy and other chronic convulsive diseases. J A Churchill, London, 1881.
32. Green PS, Simpkins JW: Estrogens and estrogen-like non-feminizing compounds. Their role in the prevention and treatment of Alzheimer's disease. Ann NY Acad Sci, 2000, 924, 93-98.
33. Guennoun R, Fiddes RJ, Gouezou M, Lombes M, Baulieu EE: A key enzyme in the biosynthesis of neurosteroids, 3b-hydroxysteroid dehydrogenase/D5-D4- isomerase (3b-HSD), is expressed in rat brain. Brain Res Mol Brain Res, 1995, 30, 287-300.
34. Hernández ML, Fernández-Ruiz JJ, de Miguel R: Timedependent effects of ovarian steroids on tyrosine hydroxylase activity in the limbic forebrain of female rats. J Neural Transm Gen Sect, 1991, 83, 77-84.
35. Herzog AG: Progesterone therapy in women with complex partial and secondary generalized seizures. Neurology, 1995, 45, 1600-1662.
36. Herzog AG: Progesterone therapy in women with epilepsy a 3-year follow-up. Neurology, 1999, 52, 1917-1918.
37. Herzog AG, Klein P, Ransil BJ: Three patterns of catamenial epilepsy. Epilepsia, 1997, 38, 1082-1088.
38. Hoffman GE, Moore N, Fiskum G, Murphy AZ: Ovarian steroid modulation of seizure severity and hippocampal cell death after kainic acid treatment. Exp Neurol, 2003, 182, 124-34.
39. Holmes GL, Weber DA: The effect of progesterone on kindling: a developmental study. Brain Res, 1984, 318, 45-53.
40. Horn AC, Buterbaugh GG: Estrogen alters the acquisition of seizures kindled by repeated amygdala stimulation or pentylenetetrazol administration in ovariectomized female rats. Epilepsia, 1986, 27, 103-108.
41. Jacono JJ, Robertson JM: The effects of estrogen, progesterone, and ionized calcium on seizures during the menstrual cycle of epileptic women. Epilepsia, 1987, 28, 571-577.
42. Jover T: Estrogen protect against global ischemic induced neuronal death and prevent activation of apoptotic signalling cascades in the hippocampal. J Neurosci, 2002, 22, 2115-2124.
43. Kabbadj K, El-Etr M, Baulieu EE, Robel P: Pregnenolone metabolism in rodent embryonic neurons and astrocytes. Glia, 1993, 7, 170-175.
44. Kalkbrenner KA, Standley CA: Estrogen modulation of NMDA-induced seizures ovariectomized and nonovariectomized rats. Brain Res, 2003, 28, 244-9.
45. Kokate TG, Banks MK, Magee T, Yamaguchi S, Rogawski MA: Finasteride, a 5a-reductase inhibitor, blocks the anticonvulsant activity of progesterone in mice. J Pharmacol Exp Ther, 1999, 288, 679-684.
46. Kokate TG, Cohen AL, Karp E, Rogawski MA: Neuroactive steroids protect against pilocarpine- and kainic acid-induced limbic seizures and status epilepticus in mice. Neuropharmacology, 1996, 35, 1049-1056.
47. Kumon Y, Kim SC, Tompkins P: Neuroprotective effect of postischemic administration of progesterone in spontaneously hypertensive rats with focal cerebral ischemia. J Neurosurg, 2000, 92, 848-852.
48. Laidlaw J: Catamenial epilepsy. Lancet, 1956, 271, 1235-1237.
49. Landgren S, Bäckström T, Kalistratov G: The effect of progesterone on the spontaneous interictal spike evoked by the application of penicillin to the cat's cerebral cortex. J Neurol Sci, 1978, 36, 119-133.
50. Lasoñ W: Effects of estrogens on seizures and neurotoxicity. Pol J Pharmacol, 2000, 52, 59-62.
51. Lewandowski SKK, Kaczmarek L: Estrogen receptor potential functional significance of a variety of mRNA isoforms. FEBS Lett, 2002, 524, 1-5.
52. Lin C-Y, Ström A, Vega VB, Kong SL, Li A, Yeo AL, Thomsen JS et al.: Discovery of estrogen receptor a target genes and response elements in breast tumor cells. Genome Biol, 2004, 5, R66.
53. Locock C: Discussion of paper by EH Sieveking. Analysis of 52 cases of epilepsy observed by the author. Lancet, 1857, 1, 527-528.
54. Logothetis J, Harner R: Electrocortical activation by estrogens. Arch Neurol, 1960, 3, 290-297.
55. Logothetis J, Harner R, Morrel F: The role of estrogens in catamenial exacerbation of epilepsy. Neurology, 1959, 9, 352-360.
56. Lonsdale D, Burnham WM: The anticonvulsant effects of progesterone and 5a-dihydroprogesterone on amygdala-kindled seizures in rats. Epilepsia, 2003, 44, 1494-1499.
57. Lu W, Wen-qin CAI, Zhong Y: Effects of estrogen on astrocyte and synaptic plasticity in hippocampus of PTZ kindling rat model of epilepsy. Acta Academic Medicinae Militaris Tertiae, 2006, 4, 280-286.
58. Maclusky NJ, Luine V, Hajszan T: The 17a and 17b isomers of estradiol both induce rapid spine synapse formation in the CA1 hippocampal subfield of ovariectomized female rats. Endocrinology, 2005, 146, 287-293.
59. Mani SK, Allen JMC, Lydon JP, Mulac-Jericevic B, Blaustein JD, DeMayao FJ, Conneely O, O'Malley BW: Dopamine requires the unoccupied progesterone receptor to induce sexual behavior in mice. Mol Endocrinol, 1996, 10, 1728-1737.
60. Mani SK, Mitchell A, O'Malley BW: Progesterone receptor and dopamine receptors are required in D9-tetrahydrocannabinol modulation of sexual receptivity in female rats. Proc Natl Acad Sci USA, 2001, 98, 1249-1254.
61. Marcus EM, Watson CW, Goldman PL: Effects of steroids on cerebral electrical activity. Epileptogenic effects of conjugated estrogens and related compounds in the cat and rabbit. Arch Neurol, 1966, 15, 521-532.
62. Matthews J, Gustafsson JA: Estrogen signalling a subtle balance between ER a and ERb. Mol Interv, 2003, 3, 281-292.
63. McEwen BS, Lee SJ: Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications. Annu Rev Pharmacol, Toxicol, 2001 41, 569-591.
64. McEwen BS, Segarra AC: Estrogen increases spine density in ventromedial hypothalmic neurons of peripubertal rats. Neuroendocrinology, 1991, 54, 365-372.
65. Mellon SH, Griffin LD, Compagnone NA: Biosynthesis and action of neurosteroids. Brain Res Rev, 2001, 37, 3-12.
66. Mohammad S, Abolhassan A, Pourgholami MH: Evaluation of the anticonvulsant profile of progesterone in male amygdala-kindled rats. Epilepsy Res, 1998, 30, 195-202.
67. Monnet FP, Mahe V, Robel P, Baulieu EE: Neurosteroids, via s receptors, modulate the [3H] norepinephrine release evoked by N-methyl-D-Aspartate in the rat hippocampus. Proc Natl Acad Sci USA, 1995, 92, 3774-3778.
68. Morali G, Letechipia-Vallejo G, Lopez-Loeza E: Postischemic administration of progesterone in rats exerts neuroprotective effects on the hippocampus. Neurosci Lett, 2005, 382, 286-290.
69. Moran MH, Smith S: Progesterone withdrawal, proconvulsant effects. Brain Res, 1998, 807, 84-90.
70. Morrell MJ: Epilepsy in women: the science of why it is special. Neurology, 1999, 53, S42-S48.
71. Motta E, Golba A, Ostrowska Z, Steposz A, Huc M, Rusnak JK, Luszczki JJ et al.: Progesterone therapy in women with epilepsy. Pharmacol Rep, 2013, 65, 89-98.
72. Mulac-Jericevic B, Mullinax RA, DeMayo FJ, Lydon JP, Conneely OM: Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science, 2000, 289, 1751-1754.
73. Murphy DD, Cole NB, Greenberger V, Segal M: Estradiol increases dendritic spine density by reducing GABA neurotransmission in hippocampal neurons. J Neurosci, 1998, 18, 2550-2559.
74. Nelson LR, Bulun SE: Estrogen production and action. J Am Acad Dermatol, 2001, 45, S116-124.
75. Parsons B, Rainbow TC, MacLusky NJ, McEwen BS: Progestin receptor levels in rat hypothalamic and limbic nuclei. J Neurosci, 1982, 2, 1446-1452.
76. Perez J, Zucchi I, Maggi A: Estrogen modulation of the g-Aminobutyric acid receptor complex in the central nervous system of rat. J Pharmacol Exp Ther, 1988, 244, 1005-1010.
77. Pozzo-Miller LD, Inoue T, Murphy DD: Estradiol increases spine density and NMDA dependent calcium transients in spines of CA1 pyramidal neurons from hippocampal slices. J Neurophysiol, 1999, 81, 1404-1411.
78. Ramirez VD, Zheng J, Siddique KM: Membrane progesterone receptors for estrogen, progesterone and testosterone in the rat brain fantasy or reality. Cell Mol Neurobiol, 1996, 16, 175-198.
79. Reddy DS: Role of neurosteroids in catamenial epilepsy. Epilepsy Res, 2004, 62, 99-118.
80. Reddy DS: The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy. Epilepsy Res, 2009, 85, 1-30.
81. Reddy DS: The role of neurosteroids in the pathophysiology and treatment of epilepsy. Epilepsy Res, 2008, 83, 12-39.
82. Reibel S, Vivien-Roels B, Le BT, Larmet Y, Carnahan J, Marescaux C, Depaulis A: Overexpression of neuropeptide Y induced by brain-derived neurotrophic factor in the rat hippocampus is long lasting. Eur J Neurosci, 2000, 12, 595-605.
83. Roof RL, Duvdevani R, Heyburn JW, Stein DG: Progesterone rapidly decreases brain edema: treatment delayed up to 24 hours is still effective. Exp Neurol, 1996, 138, 246-251.
84. Roof RL, Hoffman SW, Stein DG: Progesterone protects against lipid peroxidation following traumatic brain injury in rats. Mol Chem Neuropathol, 1997, 31, 1-11.
85. Rudick CN, Woolley CS: Estrogen regulates functional inhibition of hippocampal CA1 pyramidal cells in the adult female rat. J Neurosci, 2001, 21, 6532-6543.
86. Saberi M, Pourgholami MH, Jorjani M: The acute effects of estradiol benzoate on amygdala-kindled seizures in male rats. Brain Res, 2001, 891, 1-6.
87. Sayeed I, Guo Q, Hoffman SW: Allopregnanolone, a progesterone metabolite, is more effective than progesterone in reducing cortical infarct volume after transient middle cerebral artery occlusion. Ann Emerg Med, 2006, 47, 381-389.
88. Sayeed I, Wali B, Stein DG: Progesterone inhibits ischemic brain injury in a rat model of permanent middle cerebral artery occlusion. Restor Neurol Neurosci, 2007, 25, 151-159.
89. Schultz-Krohn WA, Thompson J, Holmes GL: Effect of systemic estrogen on seizure susceptibility in the immature animal. Epilepsia, 1986, 27, 538-541.
90. Schwartz-Giblin S, Korotzer A, Pfaff DW: Steroid hormone effects on picrotoxin- induced seizures in female and male rats. Brain Res, 1989, 476, 240-247.
91. Selye H: The antagonism between anesthetic steroid hormones and pentamethylenetetrazol (metrazol). J Lab Clin Med, 1942, 27, 1051-1053.
92. Shear DA, Galani R, Hoffman SW, Stein DG: Progesterone protects against necrotic damage and behavioral abnormalities caused by traumatic brain injury. Exp Neurol, 2002, 178, 59-67.
93. Slamberova R, Vathy I: Estrogen differentially alters NMDA- and kainate-induced seizures in prenatally morphine- and saline-exposed adult female rats. Pharmacol Biochem Behav, 2000, 67, 501-505.
94. Smith SS, Gong QH, Hsu FC, Markowitz RS, french- Mullen JMH, Li X: GABAA receptor a4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature, 1998, 392, 926-930.
95. Smith SS, Waterhouse BD, Woodward DJ: Locally applied estrogens potentiate glutamate-evoked excitation of cerebellar Purkinje cells. Brain Res, 1988, 475, 272-282.
96. Sridharan R: Epidemiology of epilepsy. Current Science, 2002, 82, 664.
97. Sridharan R, Murthy BN: Prevalence and pattern of epilepsy in India. Epilepsia, 1999, 40, 631-636.
98. Terasawa E, Timiras PS: Electrical activity during the estrous cycle of the rat cyclical changes in limbic structures. Endocrinology, 1968, 83, 207-216.
99. Tominaga K, Yamauchi A, Shuto H, Niizeki M, Makino K, Oishi R: Ovariectomy aggravates convulsions and hippocampal g-Aminobutyric acid inhibition induced by cyclosporin A in rats. Eur J Pharmacol, 2001, 430, 243-249.
100. Toran-Allerand CD, Guan X, MacLusky NJ, Horvath TL, Diano S, Singh M, Connolly Jr ES et al.: ER-X a novel plasma membrane-Associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. J Neurosci, 2002, 2, 8391-8401.
101. Tsai MJ, O'Malley BW: Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem, 1994, 63, 451-486.
102. Velísek L, Velisková J, Etgen AM, Stanton PK, Moshe SL: Region-specific modulation of limbic seizure susceptibility by ovarian steroids. Brain Res, 1999, 842, 132-138.
103. Velisková J: Estrogens and epilepsy: why are we so excited?. Neuroscientist, 2007, 13, 77-88.
104. Velisková J: The role of estrogen in seizures and epilepsy: the bad guys or the good guys? Neuroscience, 2006, 138, 837-844.
105. Velisková J, Velisek L, Galanopoulou AS, Sperber EF: Neuroprotective effects of estrogen on hippocampal cells in adult female rats after status epilepticus. Epilepsia, 2000, 41 Suppl 6, s30-35.
106. Voiculescu V, Hategan D, Manole E, Ulmeanu A: Increased susceptibility to audiogenic seizures following withdrawal of progesterone. Rom J Neurol Psychiatry, 1994, 32, 131-133.
107. Werboff LH, Havlena J: Audiogenic seizures in adult male rats treated with various hormones. Gen Comp Endocrinol, 1963, 8, 389-397.
108. Wise PM, Dubal V, Wilson ME, Rau SW, Bottner M, Rosewell KL: Estradiol is a protective factor in the adult and aging brain: understanding of mechanisms derived from in vivo and in vitro studies. Brain Res Rev, 2001, 37, 313-319.
109. Wong M, Moss RL: Patch-clamp analysis of direct steroidal modulation of glutamate receptor-channels. J Neuroendocrinol, 1994, 6, 347-355.
110. Woolley CS: Estradiol facilitates kainic acid-induced, but not flurothyl-induced, behavioral seizure ativity in adult female rats. Epilepsia, 2000, 41, 510-515.
111. Woolley CS, McEwen BS: Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-Aspartate receptor-dependent mechanism. J Neurosci, 1994, 14, 7680-7687.
112. Woolley CS, Weiland NG, McEwen BS, Schwartzkroin PA: Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input correlation with dendritic spine density. J Neurosci, 1997, 17, 1848-1859.
113. Woolley DE, Timiras PS: Estrous and circadian periodicity and electroshock convulsions in rats. Am J Physiol, 1962, 202, 379-382.
114. Woolley DE, Timiras PS: The gonad-brain relationship effects of female sex hormones on electroshock convulsions in the rat. Endocrinology, 1962, 70, 196-209.
115. Woolley DE, Timiras PS, Woodbury DM: Some effects of sex steroids on brain excitability and metabolism. Proc West Pharmacol Soc, 1960, 3, 11-23.
116. Wright DW, Bauer ME, Hoffman SW, Stein DG: Serum progesterone levels correlate with decreased cerebral edema after traumatic brain injury in male rats. J Neurotrauma, 2001, 18, 901-909.
117. Wu FS, Gibbs TT, Farb DH: Inverse modulation of gamma aminobutyric acid- and glycine-induced currents by progesterone. Mol Pharmacol, 1990, 37, 597-602.